RESUMEN
AIM: Procedures normally performed in the hospital setting are increasingly delivered as part of hospital at home (HAH) programmes. The aim of this study is to describe the procedures and diseases treated during the first 2 years of a new paediatric HAH programme. METHODS: This is a retrospective, observational study conducted in the HAH programme of Niño Jesús Children's Hospital (Spain). We included demographic data, diagnosis and procedures delivered to patients admitted to the HAH programme from November 2018 to November 2020. RESULTS: There were 935 admissions of 833 patients. The median age was 5 years (interquartile range 2.3-9.5). Seventy-five percent of patients were previously healthy. The most frequent illnesses were acute infections (37%) (e.g. complicated appendicitis and ENT, genitourinary, skin and soft tissue infections) and acute respiratory diseases (17.3%) (e.g. asthma, bronchiolitis and pneumonia). Thirty-six percent of admissions underwent nocturnal polysomnography. The median length of stay was 4 days (SD 4.9 days). Eight percent of the episodes studied required care in the emergency department due to condition worsening (55.3%) and problems with devices (36.1%). Hospital readmission was required in 5.6% of cases, 42.4% of which later resumed care in the HAH. The estimated daily cost of HAH is 330.65 euros, while the hospital per-day costs of polysomnography, asthma and endovenous therapy are 1899.24, 1402.5, and 976.26 euros. Ninety percent of families reported a high level of satisfaction. CONCLUSIONS: Paediatric HAH programmes are a feasible, cost-effective alternative to hospital care. Further studies should compare the evolution of patients treated in the traditional hospital setting and those in HAH.
Asunto(s)
Asma , Servicios de Atención de Salud a Domicilio , Enfermedad Aguda , Niño , Preescolar , Estudios de Seguimiento , Hospitales , HumanosRESUMEN
Streptococcus dysgalactiae subspecies equisimilis infection is an emerging pathogen. Cutaneous and systemic manifestations resemble those of other pyogenic streptococci. However, the rapid group A antigen detection test used to diagnose Streptococcus pyogenes infection is usually negative, making the diagnosis difficult. If clinical suspicion of streptococcal infection is high, a tonsillar culture should be performed to confirm the diagnosis.
Asunto(s)
Exantema , Infecciones Estreptocócicas , Niño , Humanos , Infecciones Estreptocócicas/diagnóstico , StreptococcusRESUMEN
INTRODUCTION: There are many initiatives aimed at eliminating health care interventions of limited utility in clinical practice. The Committee on Care Quality and Patient Safety of the Spanish Association of Pediatrics (AEP) has proposed the development of "DO NOT DO" recommendations (DNDRs) to establish a series of practices to be avoided in the care of paediatric patients in primary, emergency, inpatient and home-based care. MATERIAL AND METHODS: The project was carried out in 2 phases: a first phase in which possible DNDRs were proposed, and a second in which the final recommendations were established by consensus using the Delphi method. Recommendations were proposed and evaluated by members of the professional groups and paediatrics societies invited to participate in the project under the coordination of members of the Committee on Care Quality and Patient Safety. RESULTS: A total of 164 DNDRs were proposed by the Spanish Society of Neonatology, the Spanish Association of Primary Care Paediatrics, the Spanish Society of Paediatric Emergency Medicine, the Spanish Society of Internal Hospital Paediatrics and the Medicines Committee of the AEP and the Spanish Group of Paediatric Pharmacy of the Spanish Society of Hospital Pharmacy. The initial set was limited to 42 DNDRs, and the selection over successive rounds yielded a final set of 25 DNDRs, with 5 DNDRs for each paediatrics group or society. CONCLUSIONS: This project allowed the selection and establishment by consensus of a series of recommendations to avoid unsafe, inefficient or low-value practices in different areas of paediatric care, which may contribute to improving the safety and quality of paediatric clinical practice.
Asunto(s)
Neonatología , Medicina de Urgencia Pediátrica , Pediatría , Humanos , Niño , Calidad de la Atención de SaludRESUMEN
Advances in medical care have increased the survival of children with complex chronic pathology (CCP). OBJECTIVE: to analyze the epidemiological and clinical characteristics of a cohort of children with CCP. PATIENTS AND METHOD: retrospective descriptive study performed in a tertiary hospital bet ween June 2017 and June 2020, which included patients with CCP criteria. Epidemiological, clinical, admissions, and services involved data were collected and analyzed. Statistical analysis was perfor med using SPSS v22.0 software. RESULTS: 323 patients (mean age 7 years) were included. 93.1% had a multisystem disease, with neurological (87.3%) and gastrointestinal (34.1%) as the most frequent chronic conditions. 39.9% were technology dependent. The main diagnoses were Infantile Cerebral Palsy (23.5%) and Epileptic Encephalopathy (13.9%). Each patient was in follow-up by 5 specialists on average. Of the patients, 85.1% were admitted at some time, with a total of 739 admissions. The mean length of stay was 8.7 days. Technology-dependent patients accounted for 54.7% of hospi talizations. The reasons for admission were acute illness (64.3%), surgery (20.3%), and diagnostic procedure (15%). ICU was required in 23.1%. 62 admissions were partially carried out by the Home Hospitalization Unit. CONCLUSIONS: Children with CCP require an increased number of admissions and multiple specialists. The implementation of specialized referral units may be useful to improve their care.
Asunto(s)
Hospitalización , Unidades de Cuidados Intensivos , Niño , Humanos , Estudios Retrospectivos , HospitalesRESUMEN
Our study describes more than 100 children hospitalized with pneumonia during lockdown in the first pandemic wave with only 20% attributable to SARS-CoV-2. The serologic study during follow-up only helped to detect 4%. Other etiologies were common. Older age, presence of headache, vomiting, lymphopenia and thrombopenia were associated with COVID-19 pneumonia.
Asunto(s)
COVID-19/complicaciones , Pandemias , Neumonía/etiología , SARS-CoV-2/aislamiento & purificación , COVID-19/epidemiología , COVID-19/virología , Niño , Niño Hospitalizado , Preescolar , Femenino , Hospitales Universitarios , Humanos , Lactante , Masculino , Neumonía/epidemiología , Neumonía/virología , SARS-CoV-2/genética , España/epidemiología , Centros de Atención TerciariaRESUMEN
A new paediatric multisystem inflammatory syndrome, linked to SARS-CoV-2, has been described. The clinical picture is variable and is associated with an active or recent infection due to SARS-CoV-2. A review of the existing literature by a multidisciplinary group of paediatric specialists is presented in this document. Later, they make recommendations on the stabilisation, diagnosis, and treatment of this syndrome.
Asunto(s)
COVID-19/diagnóstico , COVID-19/terapia , Síndrome de Respuesta Inflamatoria Sistémica/diagnóstico , Síndrome de Respuesta Inflamatoria Sistémica/terapia , Algoritmos , Niño , HumanosRESUMEN
The SARS-CoV2 pandemic dimension has affected the Hospital Pediatrics Medicine assistance in our country. New challenges generated by COVID-19 require a series of proactive measures, based on existing scientific knowledge and standards of good practice, that allow the Pediatric Hospital services readiness and operability. Hospital Internal Pediatrics, as responsible of integral care of the hospitalized child, plays a leading role in the new hospital model emerging from this crisis. This review analyzes the impact of the current SARS-CoV2 epidemic on pediatric care, and perspective of new COVID-19 outbreaks in coexistence with other viral infections. Changes secondary to pandemic involved in Hospital pediatric units must be analyzed, and how to prepare for future epidemics, also the involvement of pediatric units in adult care and the possible opportunities for improvement. Assistance of patients with chronic complex conditions in epidemic circumstances, safety aspects, opportunities for teaching and ethical considerations are reviewed. The Spanish Society of Hospital Pediatrics Medicine offers with this article a series of resources for Internal pediatric Medicine practitioners responsible to face next challenges in pediatric hospitalization units.
La dimensión de la pandemia por SARS-CoV2 ha afectado a la organización asistencial de la Pediatría Hospitalaria de nuestro país. Los nuevos retos generados por la COVID-19 exigen una serie de medidas proactivas basadas en los conocimientos científicos existentes y las normas de buena práctica, que permitan la preparación y la mayor operatividad de los servicios pediátricos hospitalarios. La Pediatría Interna Hospitalaria, como responsable de la atención integral del niño hospitalizado, tiene un papel principal en el nuevo modelo de hospital surgido de esta epidemia. En la presente revisión se analiza la repercusión pediátrica que ha tenido la epidemia por SARS-CoV2 y la preparación ante futuros rebrotes, en posible coexistencia con otras infecciones virales. Se revisa también la implicación de las unidades pediátricas en la asistencia de adultos y la atención de pacientes crónicos complejos y se ofrecen recomendaciones sobre aspectos de seguridad, consideraciones éticas y docencia de los futuros pediatras durante la crisis. La Sociedad Española de Pediatría Hospitalaria (SEPHO) pretende con este documento ofrecer a los pediatras internistas hospitalarios una serie de reflexiones y recursos de utilidad en un escenario con muchas incertidumbres.
RESUMEN
SARS-CoV-2 pandemic dimension has affected the Hospital Pediatrics Medicine assistance in our country. New challenges generated by COVID-19 require a series of proactive measures, based on existing scientific knowledge and standards of good practice, that allow the Pediatric Hospital services readiness and operability. Hospital Internal Pediatrics, as responsible of integral care of the hospitalized child, plays a leading role in the new hospital model emerging from this crisis. This review analyzes the impact of the current SARS-CoV-2 epidemic on pediatric care, and perspective of new COVID-19 outbreaks in coexistence with other viral infections. Changes secondary to pandemic involved in Hospital Pediatric units, how to prepare for future epidemics, also the involvement of pediatric units in adult care and the possible opportunities for improvement need to be revised. Assistance of patients with chronic complex conditions in epidemic circumstances, safety aspects, opportunities for teaching and ethical considerations are reviewed. The Spanish Society of Hospital Pediatrics Medicine offers with this article a series of resources for Internal Pediatric Medicine practitioners responsible to face next challenges in pediatric hospitalization units.
Asunto(s)
Infecciones por Coronavirus , Atención a la Salud/métodos , Hospitalización , Hospitales Pediátricos/organización & administración , Pandemias , Pediatría/métodos , Neumonía Viral , Betacoronavirus , COVID-19 , Niño , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/prevención & control , Atención a la Salud/organización & administración , Salud Global , Humanos , Control de Infecciones/métodos , Control de Infecciones/organización & administración , Pandemias/prevención & control , Pediatría/organización & administración , Neumonía Viral/epidemiología , Neumonía Viral/prevención & control , SARS-CoV-2RESUMEN
BACKGROUND: Kawasaki disease (KD) is an acute self-limited systemic vasculitis of unknown etiology affecting mainly children less than 5 years of age. Risk factors for cardiac involvement and resistance to treatment are insufficiently studied in non-Japanese children. OBJECTIVE: This study aimed to investigate the epidemiology, clinical features and risk factors for resistance to treatment and coronary artery lesions (CAL) in KD in Spain. METHODS: Retrospective study (May 2011-June 2016) of all patients less than 16 years of age diagnosed with KD included in KAWA-RACE network (84 Spanish hospitals). RESULTS: A total of 625 cases were analyzed, 63% were males, 79% under 5 year-olds and 16.8% younger than 12 months. On echocardiographic examination CAL were the most frequent findings (23%) being ectasia the most common (12%). Coronary aneurysms were diagnosed in 9.6%, reaching 20% in infants under 12 months (p<0.001). A total of 97% of the patients received intravenous immunoglobulin (IVIG) with a median number of days from fever onset to IVIG administration of 7.2. A second dose was given to 15.7% and steroids to 14.5% patients. Only 1.4% patients received infliximab. No deaths were reported. A multivariate analysis identified anemia, hypoalbuminemia, hyponatremia, higher creatinine and procalcitonin as independent risk factors for treatment failure and length under 103 cm, hemoglobin < 10.2 mg/dL, platelets > 900,000 cells/mm3, maximum temperature < 39.5°C, total duration of fever > 10 days and fever before treatment ≥ 8 days as independent risk factors for developing coronary aneurysms. CONCLUSIONS: In our population, children under 12 months develop coronary aneurysms more frequently and children with KD with anemia and leukocytosis have high risk of cardiac involvement. Adding steroids early should be considered in those patients, especially if the treatment is not started before 8 days of fever. A score applicable to non-Japanese children able to predict the risk of aneurysm development and IVIG resistance is necessary.
Asunto(s)
Aneurisma Coronario/complicaciones , Síndrome Mucocutáneo Linfonodular/complicaciones , Síndrome Mucocutáneo Linfonodular/epidemiología , Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Masculino , Síndrome Mucocutáneo Linfonodular/diagnóstico , Síndrome Mucocutáneo Linfonodular/terapia , Pronóstico , Factores de Riesgo , España/epidemiología , Resultado del TratamientoRESUMEN
Introducción: Muchas son las iniciativas encaminadas a eliminar intervenciones clínicas de poco valor en la asistencia sanitaria. Desde el Comité de Calidad Asistencial y Seguridad del Paciente de la Asociación Española de Pediatría, se ha propuesto la elaboración de recomendaciones de «no hacer» (RNH) con el objetivo de señalar una serie de prácticas evitables en la atención del paciente pediátrico en atención primaria, urgencias, hospitalización y domicilio. Material y métodos: Este trabajo se desarrolló en 2fases: una primera en la que se propusieron posibles RNH y una segunda en la que se consensuaron las recomendaciones finales mediante el método Delphi. Tanto las propuestas como las evaluaciones partieron de miembros de los grupos y sociedades pediátricas a los que se les realizó la propuesta, coordinados por miembros del Comité de Calidad Asistencial y Seguridad del Paciente. Resultados: Fueron propuestas un total de 164 RNH por la Sociedad Española de Neonatología, la Asociación Española de Pediatría de Atención Primaria, la Sociedad Española de Urgencias de Pediatría, la Sociedad Española de Pediatría Interna Hospitalaria y el Comité de Medicamentos de la Asociación Española de Pediatría con el Grupo Español de Farmacia Pediátrica de la Sociedad Española de Farmacia Hospitalaria. Se logró reducir el conjunto inicial a 42 RNH y en sucesivas fases se llegó a la selección final de 25 RNH, 5 RNH por cada grupo o sociedad. Conclusiones: Este proyecto ha permitido seleccionar y consensuar una serie de recomendaciones para evitar prácticas inseguras, ineficientes o de escaso valor en distintos ámbitos de la atención pediátrica, lo que podría resultar útil para mejorar la seguridad y la calidad de nuestra actividad asistencial. (AU)
Introduction: There are many initiatives aimed at eliminating health care interventions of limited utility in clinical practice. The Committee on Care Quality and Patient Safety of the Spanish Association of Pediatrics has proposed the development of «do not do» recommendations (DNDRs) to establish a series of practices to be avoided in the care of paediatric patients in primary, emergency, inpatient and home-based care. Material and methods: The project was carried out in 2 phases: a first phase in which possible DNDRs were proposed, and a second in which the final recommendations were established by consensus using the Delphi method. Recommendations were proposed and evaluated by members of the professional groups and paediatrics societies invited to participate in the project under the coordination of members of the Committee on Care Quality and Patient Safety. Results: A total of 164 DNDRs were proposed by the Spanish Society of Neonatology, the Spanish Association of Primary Care Paediatrics, the Spanish Society of Paediatric Emergency Medicine, the Spanish Society of Internal Hospital Paediatrics and the Medicines Committee of the Spanish Association of Pediatrics and the Spanish Group of Paediatric Pharmacy of the Spanish Society of Hospital Pharmacy. The initial set was limited to 42 DNDRs, and the selection over successive rounds yielded a final set of 25 DNDRs, with 5 DNDRs for each paediatrics group or society. Conclusions: This project allowed the selection and establishment by consensus of a series of recommendations to avoid unsafe, inefficient or low-value practices in different areas of paediatric care, which may contribute to improving the safety and quality of paediatric clinical practice. (AU)
Asunto(s)
Humanos , Pediatría , Atención Médica , España , 55790 , SociedadesRESUMEN
INTRODUCTION: Fever is a common cause of paediatric admissions in emergency departments. An aetiological diagnosis is difficult to obtain in those less than 3 months of age, as they tend to have a higher rate of serious bacterial infection (SBI). The aim of this study is to find a predictor index of SBI in children under 3 months old with fever of unknown origin. METHODS: A study was conducted on all children under 3 months of age with fever admitted to hospital, with additional tests being performed according to the clinical protocol. Rochester criteria for identifying febrile infants at low risk for SBI were also analysed. A predictive model for SBI and positive cultures was designed, including the following variables in the maximum model: C-reactive protein (CRP), procalcitonin (PCT), and meeting not less than four of the Rochester criteria. RESULTS: A total of 702 subjects were included, of which 22.64% had an SBI and 20.65% had positive cultures. Children who had SBI and a positive culture showed higher values of white cells, total neutrophils, CRP and PCT. A statistical significance was observed with less than 4 Rochester criteria, CRP and PCT levels, an SBI (area under the curve [AUC] 0.877), or for positive cultures (AUC 0.888). Using regression analysis a predictive index was calculated for SBI or a positive culture, with a sensitivity of 87.7 and 91%, a specificity of 70.1 and 87.7%, an LR+ of 2.93 and 3.62, and a LR- of 0.17 and 0.10, respectively. CONCLUSIONS: The predictive models are valid and slightly improve the validity of the Rochester criteria for positive culture in children less than 3 months admitted with fever.
Asunto(s)
Infecciones Bacterianas/diagnóstico , Fiebre de Origen Desconocido/microbiología , Modelos Estadísticos , Antibacterianos/uso terapéutico , Infecciones Bacterianas/complicaciones , Infecciones Bacterianas/tratamiento farmacológico , Humanos , Lactante , Pronóstico , Estudios Prospectivos , Índice de Severidad de la EnfermedadAsunto(s)
Parálisis Facial , Mastoiditis , Otitis Media , Enfermedad Aguda , Antibacterianos/uso terapéutico , Niño , Parálisis Facial/etiología , Humanos , Lactante , Mastoiditis/complicaciones , Mastoiditis/diagnóstico por imagen , Mastoiditis/tratamiento farmacológico , Otitis Media/complicaciones , Estudios Retrospectivos , Factores de RiesgoRESUMEN
Se ha descrito un nuevo síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2. Este cuadro presenta una expresividad clínica variable y se asocia a infección activa o reciente por SARS-CoV-2. En este documento se revisa la literatura existente por parte de un grupo multidisciplinar de especialistas pediátricos. Posteriormente, se realizan recomendaciones sobre estabilización, diagnóstico y tratamiento de este síndrome
A new paediatric multisystem inflammatory syndrome, linked to SARS-CoV-2, has been described. The clinical picture is variable and is associated with an active or recent infection due to SARS-CoV-2. A review of the existing literature by a multidisciplinary group of paediatric specialists is presented in this document. Later, they make recommendations on the stabilisation, diagnosis, and treatment of this síndrome
Asunto(s)
Humanos , Niño , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/epidemiología , Neumonía Viral/complicaciones , Neumonía Viral/epidemiología , Síndrome de Respuesta Inflamatoria Sistémica/complicaciones , Consenso , Diagnóstico Diferencial , Síndrome de Respuesta Inflamatoria Sistémica/prevención & control , Hospitalización , BetacoronavirusRESUMEN
La dimensión de la pandemia por SARS-CoV-2 ha afectado a la organización asistencial de la pediatría hospitalaria de nuestro país. Los nuevos retos generados por la COVID-19 exigen una serie de medidas proactivas basadas en los conocimientos científicos existentes y las normas de buena práctica que permitan la preparación y la mayor operatividad de los servicios pediátricos hospitalarios. La pediatría interna hospitalaria, como responsable de la atención integral del niño hospitalizado, tiene un papel principal en el nuevo modelo de hospital surgido de esta epidemia. En la presente revisión se analiza la repercusión pediátrica que ha tenido la epidemia por SARS-CoV-2 y la preparación ante futuros rebrotes, en posible coexistencia con otras infecciones virales. Se revisa también la implicación de las unidades pediátricas en la asistencia de adultos y la atención de pacientes crónicos complejos, y se ofrecen recomendaciones sobre aspectos de seguridad, consideraciones éticas y docencia de los futuros pediatras durante la crisis. La Sociedad Española de Pediatría Hospitalaria (SEPHO) pretende con este documento ofrecer a los pediatras internistas hospitalarios una serie de reflexiones y recursos de utilidad en un escenario con muchas incertidumbres
SARS-CoV-2 pandemic dimension has affected the Hospital Pediatrics Medicine assistance in our country. New challenges generated by COVID-19 require a series of proactive measures, based on existing scientific knowledge and standards of good practice, that allow the Pediatric Hospital services readiness and operability. Hospital Internal Pediatrics, as responsible of integral care of the hospitalized child, plays a leading role in the new hospital model emerging from this crisis. This review analyzes the impact of the current SARS-CoV-2 epidemic on pediatric care, and perspective of new COVID-19 outbreaks in coexistence with other viral infections. Changes secondary to pandemic involved in Hospital Pediatric units, how to prepare for future epidemics, also the involvement of pediatric units in adult care and the possible opportunities for improvement need to be revised. Assistance of patients with chronic complex conditions in epidemic circumstances, safety aspects, opportunities for teaching and ethical considerations are reviewed. The Spanish Society of Hospital Pediatrics Medicine offers with this article a series of resources for Internal Pediatric Medicine practitioners responsible to face next challenges in pediatric hospitalization units
Asunto(s)
Humanos , Niño , Adulto , Hospitales Pediátricos/normas , Prioridades en Salud , Infecciones por Coronavirus/epidemiología , Neumonía Viral/epidemiología , Pandemias , Equipos de Seguridad/normas , Infecciones por Coronavirus/terapia , Neumonía Viral/terapia , Infecciones por Coronavirus/prevención & control , Neumonía Viral/prevención & control , Seguridad del PacienteRESUMEN
OBJECTIVE: The purpose of this study is to analyse whether the use of hypotonic fluids increases the risk of iatrogenic hyponatraemia in children hospitalised with acute gastroenteritis (AGE). PATIENTS AND METHODS: Prospective study carried out on 205 patients with ages ranging from 1 to 28 months and admitted with a diagnosis of mild or moderate dehydration due to AGE and treated with intravenous hypotonic fluids in a paediatric department in Madrid (Spain). The degree of dehydration at presentation was estimated using standard clinical measures. 198 children received 0.3 % glucosaline solution and in 7 patients, with baseline hypernatraemia, 0.2 % gluco-hyposaline solution was administered. We analysed the results according to whether children were hyponatraemic, normonatraemic or hypernatraemic at presentation. The blood and urine samples were analysed and the concentration of sodium and fractional sodium excretion (EFNa) before and after intervention were considered as outcome measures. RESULTS: The 205 patients included in the study were distributed in 3 groups according to the baseline natraemia results. In 37 cases we detected hyponatraemia (18.04%), in 133 cases isonatraemia (64.87%) and in 35 children hypernatraemia (17.07%). After administering hypotonic fluids we detected a significant difference between initial and final natraemia in all groups; in the group with hyponatraemia, sodium increased and in the groups with iso and hypernatraemia, sodium slightly decreased. A significant correlation between the EFNa and the evolution of natraemia was found. No cases of hyponatraemia post-infusion were seen and there was no correlation between free water administered and natraemia evolution. CONCLUSIONS: RESULTS show that the use of hypotonic fluids does not increase the risk of hospital acquired hyponatraemia in hospitalised children with normal renal function. Our children with gastroenteritis did not develop hyponatraemia even though they were all treated with hypotonic intravenous solutions.
Asunto(s)
Fluidoterapia/efectos adversos , Gastroenteritis/terapia , Hiponatremia/etiología , Soluciones Hipotónicas/efectos adversos , Enfermedad Aguda , Preescolar , Femenino , Hospitalización , Humanos , Enfermedad Iatrogénica , Lactante , Recién Nacido , Masculino , Estudios Prospectivos , Medición de RiesgoRESUMEN
Objetivo: estudiar la relación existente entre los niveles de contaminantes atmosféricos y los ingresos hospitalarios pediátricos totales y por patología respiratoria en particular. Pacientes y métodos: estudio ecológico en el cual la variable dependiente analizada han sido los ingresos pediátricos generales y aquellos por patología respiratoria, concretamente neumonías, crisis asmáticas y bronquiolitis, en un hospital del centro de Madrid durante seis años (2012-2017). Como variables independientes se estudiaron los valores promedio de contaminantes ambientales registrados en la ciudad de Madrid. Se calcularon coeficientes de correlación y regresión lineal múltiple. Se comparó el promedio de ingresos cuando los valores de dióxido de nitrógeno (NO2) eran superiores e inferiores a 40 µg/m3. Resultados: durante el periodo de tiempo estudiado se registraron 10 512 ingresos en Pediatría general, 5328 (50,68%) causados por procesos respiratorios. Se encontró una correlación entre los niveles de NO2, CO, benceno y los ingresos hospitalarios totales y respiratorios en todos los casos con un valor de p <0,0001. En la regresión lineal múltiple los ingresos totales se relacionaron con los niveles de NO2 positiva y negativamente con la temperatura, en relación con los ingresos respiratorios se incrementan con los niveles de NO2 y benceno y disminuyen con la temperatura. Se calculó que si los niveles de NO2 no hubieran superado en ningún mes los niveles de 40 µg/m3 se podrían haber evitado el 8,37% (IC 95: 7,77 a 8,98) de los ingresos totales y el 6,73% (IC 95: 6 a 7,52) de los ingresos respiratorios. Conclusiones: se encontró una relación entre los ingresos totales y por enfermedad respiratoria en la infancia y los niveles de contaminantes atmosféricos, especialmente NO2. La mejora de la calidad del aire podría evitar un porcentaje significativo de ingresos pediátricos y propiciarla debería ser tarea prioritaria para los pediatras
Objective: to assess the association between levels of airborne pollutants and paediatric hospital admissions, overall and due to respiratory problems. Patients and methods: we conducted an ecological study in which the dependent variables were the number of total paediatric hospital admissions and the number of paediatric admissions due to respiratory problems, specifically pneumonia, asthma exacerbations and bronchiolitis, in a hospital located in the centre of Madrid over a period of 6 years (2012-2017). The independent variables were the mean levels of air pollutants recorded in the city of Madrid. We calculated correlation coefficients and fit multiple linear regression models. We compared the average number of admissions when the levels of nitrogen (NO2) were above and below 40 µg/m3. Results: in the period under study, there were 10 512 admissions to the general paediatrics ward, of which 5328 (50.68%) were due to respiratory problems. We found a correlation between the levels of NO2, CO, and benzene and the number of overall admissions and respiratory admissions, in every instance with a p-value of less than 0.0001. The multiple linear regression analysis revealed that the number of overall admissions was associated with NO2 levels (positively) and temperature (negatively), while respiratory admissions were associated to NO2 and benzene levels (positively) and temperature (negatively). We estimated that if the levels of NO2 had stayed below 40 µg/m3 throughout the study period, 8.37% (95 CI: 7.77 to 8.98) of total admissions and 6.73% (95 CI: 6 to 7.52) of respiratory admissions could have been avoided. Conclusions: we found an association between the number of admissions, overall and for respiratory causes, in the paediatric age group and the levels of air pollutants, especially NO2. Improving air quality could prevent a significant proportion of paediatric hospital admissions, and promoting this change should be a priority for paediatricians
Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Adolescente , Hospitalización/estadística & datos numéricos , Contaminantes Atmosféricos/aislamiento & purificación , Contaminación del Aire/efectos adversos , Enfermedades Respiratorias/epidemiología , Tiempo de Internación/estadística & datos numéricos , Estudios Ecológicos , Contaminación Ambiental/efectos adversos , Enfermedades Respiratorias/prevención & controlRESUMEN
Introducción: las infecciones por adenovirus tienen una presentación clínica variable y son una importante causa de morbilidad en la infancia. Frecuentemente reciben tratamiento antibiótico de forma innecesaria. Este estudio busca analizar las características de los pacientes con infección por adenovirus y ver si difieren de aquellos con infección bacteriana. Pacientes y métodos: se estudiaron 174 pacientes ingresados en un hospital terciario desde enero de 2009 hasta agosto de 2017 a los que se les detectó adenovirus. Se analizaron las variables clínicas y analíticas y se compararon con las de una muestra de pacientes diagnosticados de infección bacteriana confirmada en el mismo centro en 2016. Resultados: la tasa de pacientes con infección por adenovirus fue de 1,58/100 ingresos. El 64% eran varones, siendo la edad media de 17 meses. Los que solo presentaban síntomas gastrointestinales tenían una menor edad y resultados analíticos más favorables que los que solo mostraban síntomas respiratorios. Un 24,5% presentaban coinfección por otro virus, observándose en este grupo una mayor estancia hospitalaria (7,93 frente a 6,17 días, p = 0,006). Los criterios analíticos de infección bacteriana grave no mostraron diferencias significativas al comparar entre los pacientes infectados por adenovirus y los que tenían una infección bacteriana confirmada, excepto una diferencia mínima, aunque estadísticamente significativa, al comparar las cifras de proteína C reactiva. Conclusiones: las variables analíticas y clínicas estudiadas no son suficientes para discriminar entre infección bacteriana y por adenovirus. Sería adecuado descartar infección por adenovirus sistemáticamente antes de instaurar tratamiento antibiótico
Introduction: adenovirus infections have a heterogeneous clinical presentation and are an important cause of childhood morbidity. They are frequently and unnecessarily treated with antibiotics. In this study, we analysed the characteristic of patients with adenovirus infections in order to determine whether they differed from those of patients with bacterial infection. Patients and methods: the study included 174 patients admitted to a tertiary care hospital between January 2009 and August 2017 who tested positive for adenovirus. We analysed the clinical and laboratory findings in these patients and compared them to those of a group of patients that received a diagnosis of confirmed bacterial infection in the same hospital in 2016. Results: the incidence of adenovirus was of 1.58 cases per 100 admissions. Sixty-four percent of the sample was male, and the mean age was 17 months. Patients that presented with gastrointestinal symptoms alone were younger and had more favourable laboratory findings compared to patients with respiratory symptoms alone. Coinfection with another virus was found in 24.5%, and this group had a longer length of stay (7.93 versus 6.17 days, p = 0.006). We found no significant differences in the laboratory criteria indicative of severe bacterial infection between the patients with adenovirus infection and the controls with a confirmed bacterial infection except for a very small, although statistically significant, difference in the levels of C-reactive protein. Conclusions: the clinical and laboratory parameters analysed in our study are not sufficient to discriminate between bacterial infection and adenovirus infection. Thus, it would be appropriate to rule out adenovirus infection before initiating antibiotic treatment
Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Infecciones por Adenovirus Humanos/tratamiento farmacológico , Antibacterianos/uso terapéutico , Antivirales/uso terapéutico , Infecciones Bacterianas/tratamiento farmacológico , Infecciones del Sistema Respiratorio/tratamiento farmacológico , Hospitalización/estadística & datos numéricos , Infecciones por Adenovirus Humanos/epidemiología , Adenovirus Humanos/patogenicidad , Coinfección/tratamiento farmacológico , Proteínas de Fase Aguda/análisisRESUMEN
Introducción. La enfermedad de Pompe infantil es una glucogenosis por deficiencia de la enzima alfa-glucosidasa ácida. Antes de disponer del tratamiento enzimático sustitutivo (TES) específico, la forma clásica era mortal antes de los 2 años de vida. El TES aumenta la supervivencia y mejora la función cardíaca, respiratoria y motora. Casos clínicos. Caso 1: lactante de 2 meses con hipotonía de predominio axial y portadora de sonda nasogástrica por dificultades en la succión y la deglución. Se evidenció miopatía y miocardiopatía hipertrófica. Se diagnosticó enfermedad de Pompe, se inició TES y se observó una mejoría de la función cardíaca y motora. Sin embargo, presentó infecciones respiratorias recurrentes que finalmente obligaron a una traqueostomía. Actualmente continúa con TES, camina con un andador y presenta una disfunción ventricular leve. Caso 2: lactante de 3 semanas que acudió a revisión rutinaria por su pediatra. En la exploración se apreció un soplo sistólico e hipotonía axial y proximal. En las pruebas cardiológicas se evidenció una miocardiopatía hipertrófica. Se envió al paciente a un centro de referencia donde se diagnosticó enfermedad de Pompe y un estado del material inmunológico con reactividad cruzada negativo. El paciente recibió tratamiento inmunomodulador y TES. La evolución fue favorable, aunque presentó infecciones respiratorias frecuentes. En la actualidad ha conseguido la deambulación autónoma, pero la marcha es inestable. Conclusiones. Ambos casos ilustran el nuevo fenotipo de la enfermedad de Pompe infantil tratada con TES. A pesar de las limitaciones motoras y la afectación respiratoria que presentan los pacientes, la supervivencia y la autonomía han aumentado (AU)
Introduction. Infantile-onset Pompe disease is a kind of glycogenosis resulting from a deficit of the enzyme acid alphaglucosidase. Before specific enzyme replacement therapy (ERT) became available, the classic form was fatal during the first two years of life. ERT increases survival and improves cardiac, respiratory and motor functioning. Case reports. Case 1: 2-month-old infant with predominantly axial hypotonia who required the use of a nasogastric tube as a result of difficulties in sucking and swallowing. Myopathy and hypertrophic cardiomyopathy were observed. The patient was diagnosed with Pompe disease, ERT was established and improved heart and motor functioning were noted. Nevertheless, she presented recurring respiratory infections that finally made it necessary to perform a tracheostomy. She is currently still undergoing ERT, walks with a walker and presents a mild ventricular dysfunction. Case 2: 3-week-old infant who was taken to see his paediatrician for a routine check-up. The examination revealed a systolic bruit and axial and proximal hypotonia. Cardiology tests revealed hypertrophic cardiomyopathy. The patient was sent to a referral centre, where he was diagnosed with Pompe disease and a cross-reactive immunological material-negative status. The patient received immunomodulator treatment and ERT. Progress was favourable, although he presented frequent respiratory infections. The patient is currently capable of walking by himself, although the gait is unsteady. Conclusions. Both cases illustrate the new phenotype of infantile-onset Pompe disease treated with ERT. Despite the motor limitations and respiratory involvement presented by the patients, both survival and autonomy have increased (AU)
Asunto(s)
Humanos , Femenino , Recién Nacido , Lactante , Enfermedad del Almacenamiento de Glucógeno Tipo II/terapia , Terapia de Reemplazo Enzimático/métodos , Hipotonía Muscular/etiología , alfa-Glucosidasas/uso terapéutico , Fenotipo , Factores Inmunológicos/uso terapéutico , Trastornos de Deglución/etiología , Trastornos Motores/etiología , Traqueostomía , Cardiomiopatía Hipertrófica/diagnóstico , Insuficiencia Respiratoria/terapiaRESUMEN
Objetivo: estudiar las características clínicas y demográficas, así como el uso de oseltamivir, de los niños hospitalizados por gripe en un hospital pediátrico terciario. Pacientes y métodos: estudio descriptivo observacional de niños entre 0 y 18 años ingresados en las temporadas de diciembre a mayo de 2012 a 2017 con diagnóstico confirmado microbiológicamente de gripe. Resultados: se han estudiado 166 pacientes. El porcentaje de ingresos sobre el total de ingresados en las mismas fechas osciló entre el 2,03 y el 9,69%. El mayor número de ingresos fueron en la penúltima temporada de estudio (p <0,0001). Los niños diagnosticados de gripe A presentaron una edad menor que los que lo fueron de gripe B (2,45 frente a 3,88 años, p <0,0001), no encontrándose diferencias significativas en cuanto al sexo, los días de estancia media, la necesidad de antibioterapia o de broncodilatadores. Recibieron tratamiento con oseltamivir un total de 96 niños (57,83%), 75 de ellos en la temporada 2015-2016. No se encontraron diferencias en las características de los niños que lo recibieron frente a los que no. La estancia media global fue 0,89 días mayor en aquellos niños que recibieron el antiviral, diferencia casi significativa en el total de la muestra (p = 0,052), durante la temporada 2015-2016 la duración fue 1,8 días mayor (p = 0,039). No se encontraron diferencias significativas en cuanto al porcentaje de pacientes con neumonía ni de los que precisaron ingreso en la Unidad de Cuidados Intensivos Pediátricos entre los tratados respecto a los no tratados. Conclusiones: el porcentaje de niños ingresados por gripe es importante, habiéndose incrementado en la última temporada. Los niños diagnosticados con gripe A tienen una edad significativamente menor que los que presentaron gripe B. En nuestro caso no se encontraron ventajas en el tratamiento con oseltamivir
Objective: to analyse the demographic and clinical characteristics and the use of oseltamivir in children admitted with influenza to a tertiary care children's hospital. Patients and methods: we conducted a descriptive observational study of all patients aged 0 to 18 years admitted in every December-to-May epidemic season between 2012 and 2016 with a microbiological diagnosis of influenza. Results: we reviewed the cases of 166 patients. The percentage of influenza admissions out of the total admissions during the seasons under study between 2.03% and 9.69%. The highest number of admissions occurred in the second to last season under study (p < .0001). Children with infection by influenza A were younger compared to those with influenza B (2.45 vs. 3.88 years, p < .0001), and we found no significant differences between serotypes in the sex distribution, mean length of stay or need for antibiotherapy or bronchodilators. A total of 96 children (57.83%) received oseltamivir, 75 of them in the 2015-2016 season. We found no differences in the characteristics of children treated with oseltamivir compared to those that were not. The mean length of stay was 0.89 days overall and was greater in children treated with the antiviral drug, with p-values that neared the threshold for significance in the entire sample (p = .052); the length of stay was 1.8 days longer in the 2015-2016 season (p = .039). We did not find significant differences between patients that received oseltamivir and patients that did not in the percentage that developed pneumonia or the percentage that required admission to the paediatric intensive care unit. Conclusions: the percentage of children admitted with influenza virus was substantial and increased in the last season. Children with an influenza A diagnosis were younger compared to children with influenza B. Our study did not find advantages in the use of oseltamivir
Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Adolescente , Gripe Humana/epidemiología , Hospitalización/estadística & datos numéricos , Oseltamivir/uso terapéutico , Virus de la Influenza A/patogenicidad , Virus de la Influenza B/patogenicidad , Niño Hospitalizado/estadística & datos numéricos , Distribución por Edad , Tiempo de Internación/estadística & datos numéricos , Resultado del TratamientoRESUMEN
Introducción: La fiebre es motivo frecuente de consulta pediátrica y en menores de 3 meses su diagnóstico etiológico es difícil, siendo un grupo de pacientes con mayor tasa de infección bacteriana grave (IBG). Nuestro objetivo es encontrar un modelo predictivo de IBG en menores de 3 meses con fiebre sin foco. Métodos: Se estudió a los niños menores de 3 meses con fiebre sin foco ingresados, realizándose pruebas complementarias según protocolo clínico. Se analizaron además los criterios de Rochester de bajo grado de IBG. Se diseñó un modelo predictivo de IBG y cultivo positivo, incluyendo las siguientes variables en el modelo máximo: proteína C reactiva (PCR), procalcitonina (PCT) y cumplimiento o no de menos de 4 criterios de Rochester. Resultados: Se incluyó a 702 sujetos; el 22,64% presentaba IBG y el 20,65% cultivos positivos. Los que presentaban IBG y cultivo positivo presentaron más leucocitos, neutrófilos totales, PCR y PCT. Se obtuvieron significación estadística en puntuación de Rochester menor de 4 y valores de PCR y PCT para IBG (área bajo la curva [ABC] 0,877) y para cultivos positivos (ABC 0,888). Con la regresión se obtuvieron unas fórmulas de predicción de IBG y cultivo positivo con sensibilidad del 87,7 y el 91%, especificidad del 70,1 y el 87,7%, CPP de 2,93 y 3,62 y CPN de 0,17 y 0,10, respectivamente. Conclusiones: Los modelos predictivos son válidos y mejoran discretamente la validez de los criterios de Rochester para cultivo positivo en menores de 3 meses ingresados con fiebre (AU)
Introduction: Fever is a common cause of paediatric admissions in emergency departments. An aetiological diagnosis is difficult to obtain in those less than 3 months of age, as they tend to have a higher rate of serious bacterial infection (SBI). The aim of this study is to find a predictor index of SBI in children under 3 months old with fever of unknown origin. Methods: A study was conducted on all children under 3 months of age with fever admitted to hospital, with additional tests being performed according to the clinical protocol. Rochester criteria for identifying febrile infants at low risk for SBI were also analysed. A predictive model for SBI and positive cultures was designed, including the following variables in the maximum model: C-reactive protein (CRP), procalcitonin (PCT), and meeting not less than four of the Rochester criteria. Results: A total of 702 subjects were included, of which 22.64% had an SBI and 20.65% had positive cultures. Children who had SBI and a positive culture showed higher values of white cells, total neutrophils, CRP and PCT. A statistical significance was observed with less than 4 Rochester criteria, CRP and PCT levels, an SBI (area under the curve [AUC] 0.877), or for positive cultures (AUC 0.888). Using regression analysis a predictive index was calculated for SBI or a positive culture, with a sensitivity of 87.7 and 91%, a specificity of 70.1 and 87.7%, an LR+ of 2.93 and 3.62, and a LR- of 0.17 and 0.10, respectively. Conclusions: The predictive models are valid and slightly improve the validity of the Rochester criteria for positive culture in children less than 3 months admitted with fever (AU)